The largest single gift ever to UCSF, a $185 million donation from Sanford I. “Sandy” Weill and Joan Weill, has launched the UCSF Weill Institute for Neurosciences. This new institute will provide resources to our neuroscience researchers and physicians to advance our knowledge and treatment options for diseases affecting the brain and nervous system, including psychiatric disorders.
Dr. Ann Poncelet was named Director of the Haile T. Debas Academy of Medical Educators, which is recognized as one of the nation’s premier academies in medical education. The Academy has just announced its new members for 2016, and two members of our faculty in Neurology have been honored: Susannah Cornes, MD and Cathy Lomen-Hoerth, MD, PhD. Congratulations to all for these important new roles.
The University of California has announced that Dr. Adam Boxer is a recipient of the UC Cures for Alzheimer’s Disease Initiative award to accelerate the development of promising Alzheimer’s disease research by UC scientists. The initiative focuses on cutting-edge projects primed for clinical trial.
Dr. Stephen L. Hauser, Chair of the Department of Neurology at UCSF, has released successful clinical trial results for a promising new drug that could become the first to treat a devastating progressive form of multiple sclerosis. The findings of late-phase trials found that ocrelizumab greatly reduced symptoms for progressive MS, as well as the more common relapsing and remitting form of MS.
The Atlantic Philanthropies awarded UC San Francisco and Trinity College Dublin, the University of Dublin, $177 million to create the Global Brain Health Institute, a groundbreaking venture to stem the precipitous rise in dementia by training and connecting a new generation of leaders worldwide. Dr. Bruce Miller, a behavioral neurologist and director of the Memory and Aging Center at UCSF, will lead the initiative with Ian Robertson, PhD, a neuroscientist at Trinity College.